CompletedNo phase
Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.
Key facts
- Where
- Chapel Hill, United StatesSee the site
Where in United States
- University of North Carolina Medical CenterChapel Hill, United StatesNo longer taking part
Trial details
- Who runs it
- University of North Carolina, Chapel Hill
- Trial code
- NCT06038734
- Record updated
- 27 June 2024
- Original description
Given the increased prescription of GLP-1 agonists for both diabetes and obesity management and the implications of the proposed delayed gastric emptying in the setting of an anesthetic, it is critical to determine if patients taking GLP-1 agonists have an increased rate of delayed gastric emptying. The purpose of this prospective gastric ultrasound evaluation of pre-operative patients is to determine the incidence of a full stomach despite a standard pre-operative fasting period.Read full original descriptionShow less
Given the increased prescription of GLP-1 agonists for both diabetes and obesity management and the implications of the proposed delayed gastric emptying in the setting of an anesthetic, it is critical to determine if patients taking GLP-1 agonists have an increased rate of delayed gastric emptying. The purpose of this prospective gastric ultrasound evaluation of pre-operative patients is to determine the incidence of a full stomach despite a standard pre-operative fasting period.
Inclusion: GLP-1 agonist use within previous 30 days; Appropriately fasted per standard guidelines.
Exclusion: History of gastric surgery / gastric volume reduction; Critical illness; <18 years of age; Inability to provide informed consent.